Viva Biotech Holdings (OTCMKTS:VBIZF) Sees Significant Increase in Short Interest

Viva Biotech Holdings (OTCMKTS:VBIZF) was the recipient of a significant increase in short interest during the month of August. As of August 31st, there was short interest totaling 638,598 shares, an increase of 355.8% from the August 15th total of 140,098 shares. Based on an average daily trading volume, of 109 shares, the days-to-cover ratio is currently 5,858.7 days.

Viva Biotech Price Performance

OTCMKTS:VBIZF opened at $0.19 on Friday. The business’s 50 day moving average is $0.17 and its two-hundred day moving average is $0.24. Viva Biotech has a 52 week low of $0.13 and a 52 week high of $0.20.

About Viva Biotech

Viva Biotech Ltd is a Shanghai-based contract research organization (CRO) providing integrated early-stage drug discovery services to the global pharmaceutical and biotechnology industries. The company’s offerings span target identification, fragment-based drug discovery, structure-based design, medicinal chemistry, high-throughput screening, in vitro ADME/Tox assays and antibody discovery. Viva Biotech leverages a proprietary fragment library and in-house structural biology capabilities to support hit identification and lead optimization across a broad range of therapeutic modalities.

With an emphasis on accelerating preclinical programs, the company combines X-ray crystallography, high-content cell-based assays and comprehensive pharmacokinetic profiling to help clients progress candidates from hit to lead.